Problems and prospects of developing effective therapy for common cold viruses

No effective treatment for common colds has yet been developed. Combination antiviral and anti-inflammatory therapies are the best hope for intervention after the onset of symptoms. Prophylaxis, especially in the form of vaccination, would have a major impact in disease prevention. These approaches...

Descripción completa

Detalles Bibliográficos
Autor principal: Johnston, Sebastian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1997
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133329/
https://www.ncbi.nlm.nih.gov/pubmed/9108931
http://dx.doi.org/10.1016/S0966-842X(96)10082-2
_version_ 1783517608980512768
author Johnston, Sebastian L.
author_facet Johnston, Sebastian L.
author_sort Johnston, Sebastian L.
collection PubMed
description No effective treatment for common colds has yet been developed. Combination antiviral and anti-inflammatory therapies are the best hope for intervention after the onset of symptoms. Prophylaxis, especially in the form of vaccination, would have a major impact in disease prevention. These approaches offer new avenues for treating populations at risk and are of particular significance to those with asthma or chronic bronchitis.
format Online
Article
Text
id pubmed-7133329
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71333292020-04-08 Problems and prospects of developing effective therapy for common cold viruses Johnston, Sebastian L. Trends Microbiol Article No effective treatment for common colds has yet been developed. Combination antiviral and anti-inflammatory therapies are the best hope for intervention after the onset of symptoms. Prophylaxis, especially in the form of vaccination, would have a major impact in disease prevention. These approaches offer new avenues for treating populations at risk and are of particular significance to those with asthma or chronic bronchitis. Published by Elsevier Ltd. 1997-02 2000-03-08 /pmc/articles/PMC7133329/ /pubmed/9108931 http://dx.doi.org/10.1016/S0966-842X(96)10082-2 Text en Copyright © 1997 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Johnston, Sebastian L.
Problems and prospects of developing effective therapy for common cold viruses
title Problems and prospects of developing effective therapy for common cold viruses
title_full Problems and prospects of developing effective therapy for common cold viruses
title_fullStr Problems and prospects of developing effective therapy for common cold viruses
title_full_unstemmed Problems and prospects of developing effective therapy for common cold viruses
title_short Problems and prospects of developing effective therapy for common cold viruses
title_sort problems and prospects of developing effective therapy for common cold viruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133329/
https://www.ncbi.nlm.nih.gov/pubmed/9108931
http://dx.doi.org/10.1016/S0966-842X(96)10082-2
work_keys_str_mv AT johnstonsebastianl problemsandprospectsofdevelopingeffectivetherapyforcommoncoldviruses

Ejemplares similares